Intuitive Surgical, Inc.
Intuitive Surgical Reports Strong Q2 2026 Financial Results
Summary
Intuitive Surgical, Inc. announced its financial results for the quarter ended June 30, 2026, reporting a 19% increase in revenue to $2.89 billion. The company saw a 16% growth in worldwide procedures, with da Vinci procedures up 15% and Ion procedures up 36%. Net income attributable to Intuitive Surgical, Inc. was $818 million, or $2.29 per diluted share, compared to $658 million, or $1.81 per diluted share, in the second quarter of 2025. The company also provided a financial outlook for the full year of 2026.
Profitelligence Alerts
Get alerts for ISRG
Be first to know when Intuitive Surgical, Inc. files with the SEC.
Filing Categories
Advertisement
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a pioneering company in the field of robotic-assisted, minimally invasive surgery. It is renowned for its development of the da Vinci Surgical System, which revolutionizes surgical procedures by enhancing precision, flexibility, and control beyond the physical capabilities of the human hand. The company's cornerstone product allows surgeons to perform complex surgeries through small incisions, which can lead to quicker patient recovery, reduced hospital stays, and lower complication rates. Operating predominantly in the healthcare sector, Intuitive Surgical serves a significant role in advancing surgical technology and improving patient outcomes. The company collaborates across diverse medical specialties, including urology, gynecology, and general surgery, to expand the applications and accessibility of its robust surgical systems. As an innovator in the medical device industry, Intuitive Surgical has a profound impact not only on surgical methodologies but also on the economic aspects of medical practices by potentially lowering surgical costs. It continues to shape the future of surgery with its commitment to enhancing robotic-assisted techniques.
Official SEC Documents
Advertisement